News & Events

BEAM Alliance
Members
Events

Latest news from BEAM Alliance

21 April 2026 - BEAM ALLIANCE

Integrating Biodefence into the European Competitiveness Fund: A Strategic Imperative

This new paper highlights the urgent need to recognise antimicrobial resistance (AMR) as both a public health threat and a security…

3 March 2026 - BEAM ALLIANCE

BEAM is turning 10!

What a journey since the association was founded in 2016! Since then, awareness of the looming AMR problem has grown,…

11 December 2025 - BEAM ALLIANCE

EU Reaches Landmark Agreement on Pharmaceutical Legislation Revision

After a long night of negotiations, EU co-legislators have reached a long-awaited political agreement on the revision of the Union’s…

20 October 2025 - BEAM ALLIANCE

Defining Eligibility for ‘Priority Antimicrobials’: A Critical Step for Effective PULL Incentives

The General Pharmaceutical Legislation (GPL) should provide broad guidelines for eligibility, leaving the EMA to refine the details. The GPL…

20 October 2025 - BEAM ALLIANCE

Transferable Priority Review Vouchers (TPRVs): Lessons from the US, Implications for EU

If a choice must be made, TEEV offer a clearer, more reliable incentive for SMEs, making them a more appealing…

20 October 2025 - BEAM ALLIANCE

The Future of the TEE Voucher in EU Pharmaceutical Legislation

The TEE Voucher is widely supported by SMEs, industry, and investors. Though not perfect, its predictability makes it attractive to…

No results

1 / 10

Latest news of BEAM Members

22 April 2026 - BioVersys

BioVersys completes BV100 Phase 1 clinical trial in China

The completion of this mandatory Phase 1 safety and pharmacokinetic clinical trial in China is crucial in the development of…

16 April 2026 - BioVersys

BioVersys announces first patient first visit in HABP/VABP pivotal Phase 3 RIV-TARGET trial of BV100

Achieving first patient first visit in the RIV-TARGET trial marks a significant milestone for BioVersys in the development of BV100…

15 April 2026 - BioVersys

BioVersys to present data on clinical and preclinical pipeline programs at ESCMID Global 2026

To effectively combat antimicrobial resistance, global cross-industry collaboration is of paramount importance. Clinicians, academic researchers, public-private partners, policy makers, and…

13 April 2026 - BioVersys

Data published in Nature Communications highlights unique Mechanism of Action of Alpibectir in combination with Ethionamide (AlpE)

The data provide a compelling scientific foundation in understanding the potential positioning of AlpE in future drug regimens to treat…

9 April 2026 - Basilea Pharmaceutica International

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

BAL2420 offers a new mode of action with the potential to address significant unmet medical needs in the treatment of…

31 March 2026 - BioVersys

BioVersys strengthens Ansamycin platform and NTM research through collaboration and license agreement with Hackensack Meridian Health

Early-stage partnerships with leading institutes and health centers from around the world grants us access to the best science to…

No results

1 / 72

Events

22 September 2026

GAMRIC – Global AMR Innovators Conference

The Global AMR Innovators Conference (GAMRIC) is an event that brings together researchers, academics, and industry professionals from around the…

25 June 2026

Therapeutics and Antimicrobial Resistance (AMR)

The meeting aims to strengthen cross-disciplinary connections, highlight opportunities for impact, and catalyse new initiatives in therapeutics research, outreach and…

28 April 2026

REVIVE Webinar: Natural product-inspired antibiotics: Successes and future prospects

This webinar will explore the successes of natural product-inspired antibiotics and examine their continued potential for the discovery and development…

17 April 2026

ESCMID Global 2026

ESCMID Global is the world’s premier meeting in the fields of Clinical Microbiology and Infectious Diseases.

26 March 2026

REVIVE Webinar: Journal Club: Key findings from recent publications in antimicrobial R&D

In this webinar, individuals who have co-authored publications that have had particular impact in the field of antimicrobial R&D will…

13 March 2026

REVIVE Webinar: Current developments in Clostridioides difficile prevention, therapy and R&D

REVIVE webinar being done in collaboration with the Peggy Lillis Foundation

No results

1 / 30

Legal notice | Photo credits

Connect with us

contact@beam-alliance.eu
29 Avenue Tony Garnier 69007 Lyon - France